I would think... whether the patient is on the drug or part of the placebo, the end point could come sooner if the patient dies or drastically improves, but... the 28 days +review time and reporting time are a good measure of timeline... otherwise we end up back in the same situation of incorrect assumptions that occurred yesterday, resulting in a selloff from missed expectations. Let's all work to keep expectations in line.